BRSK2, which belongs to the serine/threonine-protein kinase of the AMPK family, was recognized to be a risk factor for pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene BRSK2 and pancreatic ductal adenocarcinoma.